Marketing-authorisation holder
Emergent BioSolutions Canada Inc
10 medicines in 3 countries, as authorisation holder and manufacturer.
Loading your page…
Loading your page…
Marketing-authorisation holder
10 medicines in 3 countries, as authorisation holder and manufacturer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
10 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ANTHRASIL60 unit / vial · Solution | Anthrax immunoglobulin | Canada | Authorised | |
| Anthrasil>=60 u · Injection | Anthrax immune globulin intravenous | United States | Marketed | 2015 |
| BAT4500 unit / vial + 3300 unit / vial + 3000 unit / vial + 600 unit / vial + 5100 unit / vial + 3000 unit / vial + 600 unit / vial · Solution | Botulinum antitoxin serotype a, Botulinum antitoxin serotype b, Botulinum antitoxin serotype c, Botulinum antitoxin serotype d, Botulinum antitoxin serotype, Botulinum antitoxin serotype f | Canada | Authorised | |
| Bat>4500u · Solution | Botulism antitoxin heptavalent | United States | Marketed | 2013 |
| Cnj-016>=50,000u · Injection | Vaccinia immune globulin intravenous | United States | Marketed | 2005 |
| CNJ-01650000 unit / vial · Solution | Vaccinia immunoglobulin | Canada | Authorised | |
| HepaGam B | Hepatitis b immunoglobulin | Saudi Arabia | Authorised | |
| HepaGam B | Hepatitis b immunoglobulin | Saudi Arabia | Authorised | |
| WinRho SDF Liquid | Anti-d (rh) immunoglobulin | Saudi Arabia | Authorised | |
| WinRho SDF Liquid | Anti-d (rh) immunoglobulin | Saudi Arabia | Authorised |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Saudi Arabia | 4 | 4 | 0 | CompaniesAll medicines |
| Canada | 3 | 3 | 0 | CompaniesAll medicines |
| United States | 3 | 3 | 0 | CompaniesAll medicines |
Also in the registers of Singapore
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.